{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:24:40Z","timestamp":1787430280590,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515140197"],"award-info":[{"award-number":["2024A1515140197"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.acra.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:33:36Z","timestamp":1783456416000},"page":"3790-3802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Validation of an Interpretable Model Integrating Radiomics and Clinical Data for Predicting 70-gene Signature Risk in Breast Cancer: A Multicenter Study"],"prefix":"10.1016","volume":"33","author":[{"given":"Yunjun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.acra.2026.06.003_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.acra.2026.06.003_bib3","first-page":"480","article-title":"Systemic therapy for hormone receptor-positive\/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer","volume":"73","author":"Huppert","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3470","article-title":"Association of 70-gene signature assay findings with physicians' treatment guidance for patients with early breast cancer classified as intermediate risk by the 21-gene assay","volume":"4","author":"Tsai","year":"2018","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.acra.2026.06.003_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"issue":"30","key":"10.1016\/j.acra.2026.06.003_bib6","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1200\/JCO.23.01995","article-title":"Utility of the 70-gene MammaPrint assay for prediction of benefit from extended letrozole therapy in the NRG oncology\/NSABP B-42 trial","volume":"42","author":"Rastogi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.acra.2026.06.003_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1200\/JCO.21.02019","article-title":"Outcome of patients with an ultralow-risk 70-gene signature in the MINDACT trial","volume":"40","author":"Lopes Cardozo","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.acra.2026.06.003_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(21)00007-3","article-title":"70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age","volume":"22","author":"Piccart","year":"2021","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.acra.2026.06.003_bib9","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/j.clbc.2023.10.010","article-title":"Prediction of the MammaPrint risk group using MRI features in women with estrogen receptor-positive, HER2-negative, and 1 to 3 node-positive invasive breast cancer","volume":"24","author":"Kim","year":"2024","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12967-023-04523-7","article-title":"Nomogram prediction of the 70-gene signature (MammaPrint) binary and quartile categorized risk using medical history, imaging features and clinicopathological data among Chinese breast cancer patients","volume":"21","author":"Pan","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib11","article-title":"A nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1186\/s12885-025-14507-z","article-title":"Prediction of the 70-gene signature (MammaPrint) high versus low risk by nomograms among axillary lymph node positive and negative Chinese breast cancer patients, a retrospective study","volume":"25","author":"Lian","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12672-022-00604-z","article-title":"Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer","volume":"13","author":"Hwang","year":"2022","journal-title":"Discov Oncol"},{"issue":"2","key":"10.1016\/j.acra.2026.06.003_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.acra.2026.06.003_bib15","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230437","article-title":"Radiomics beyond the hype: a critical evaluation toward oncologic clinical use","volume":"6","author":"Horvat","year":"2024","journal-title":"Radiol Artif Intell"},{"issue":"6","key":"10.1016\/j.acra.2026.06.003_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/annonc\/mdx034","article-title":"Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology","volume":"28","author":"Limkin","year":"2017","journal-title":"Ann Oncol"},{"issue":"18","key":"10.1016\/j.acra.2026.06.003_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr1576","article-title":"A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer","volume":"11","author":"Mao","year":"2025","journal-title":"Sci Adv"},{"issue":"33","key":"10.1016\/j.acra.2026.06.003_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202503925","article-title":"A dynamic contrast-enhanced MRI-based vision transformer model for distinguishing HER2-zero, -low, and -positive expression in breast cancer and exploring model interpretability","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.acra.2026.06.003_bib19","first-page":"6785","article-title":"Attend and predict: understanding gene regulation by selective attention on chromatin","volume":"30","author":"Singh","year":"2017","journal-title":"Adv Neural Inf Process Syst"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib20","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/s41467-024-46700-2","article-title":"Development and validation of an interpretable model integrating multimodal information for improving ovarian cancer diagnosis","volume":"15","author":"Xiang","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.acra.2026.06.003_bib21","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1007\/s00259-025-07248-5","article-title":"Interpretable multimodal deep learning model for predicting post-surgical international society of urological pathology grade in primary prostate cancer","volume":"52","author":"Jiang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.acra.2026.06.003_bib22","article-title":"Radiomics in breast cancer: current advances and future directions","volume":"5","author":"Qi","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.acra.2026.06.003_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","article-title":"Radiomics in breast cancer classification and prediction","volume":"72","author":"Conti","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.acra.2026.06.003_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","article-title":"Predicting cancer outcomes with radiomics and artificial intelligence in radiology","volume":"19","author":"Bera","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.acra.2026.06.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2023.120389","article-title":"MLP-based classification of COVID-19 and skin diseases","volume":"228","author":"Zhang","year":"2023","journal-title":"Expert Syst Appl"},{"issue":"1","key":"10.1016\/j.acra.2026.06.003_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40644-025-00895-9","article-title":"Multilayer perceptron deep learning radiomics model based on Gd-BOPTA MRI to identify vessels encapsulating tumor clusters in hepatocellular carcinoma: a multi-center study","volume":"25","author":"Gu","year":"2025","journal-title":"Cancer Imaging"},{"issue":"12","key":"10.1016\/j.acra.2026.06.003_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.acra.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s43018-022-00388-9","article-title":"Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer","volume":"3","author":"Boehm","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.acra.2026.06.003_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103460","article-title":"Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: a machine learning, multicenter study","volume":"69","author":"Yu","year":"2021","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.acra.2026.06.003_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28086","article-title":"Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer","volume":"3","author":"Yu","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.acra.2026.06.003_bib31","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ijc.35514","article-title":"MR imaging of breast cancer: interpretable radiomics analysis to assess treatment response and survival prognosis after neoadjuvant therapy","volume":"157","author":"Hou","year":"2025","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.acra.2026.06.003_bib32","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/j.acra.2025.03.010","article-title":"Multiparametric MRI-based interpretable machine learning radiomics model for distinguishing between luminal and non-luminal tumors in breast cancer: a multicenter study","volume":"32","author":"Zhou","year":"2025","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1016\/j.acra.2026.06.003_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202510307","article-title":"Predicting MammaPrint recurrence risk from breast cancer pathological images using a weakly supervised transformer","volume":"13","author":"Yan","year":"2026","journal-title":"Adv Sci"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226004186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226004186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:57:44Z","timestamp":1787428664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226004186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1076633226004186"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.06.003","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Validation of an Interpretable Model Integrating Radiomics and Clinical Data for Predicting 70-gene Signature Risk in Breast Cancer: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}